Stock detail
Natera (NTRA) stock price, chart, and key data
View Natera stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Natera
NTRA · XNAS
$328.65
-0.50%
-$1.66
Key metrics
52-week range
$15.50 - $4.00
Close price
$330.31
Market cap
$47.6B
P/E ratio
-702.79
Beta
0.44
About the company
Natera Inc
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$349
20
Buy
/ 22
Recent calls
09/09/2026
UBS
Unknown Analyst
Buy · Price target $435
09/09/2026
Bernstein
Eve Burstein
Buy · Price target $365
09/08/2026
Rothschild & Co Redburn
Jamie Clark
Buy · Price target $385
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Dan Goldman democrat · House · NY-10 self |
| $2,002/$16,001/$30,000 |
#2Bill Hagerty republican · Senate · TN self |
| 631/1,105/1,579 |
#3Josh Gottheimer democrat · House · NJ-5 joint |
| 11/92/174 |
#4Donald J Trump republican · Executive self |
| 3/28/54 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app